Factors during donor care that may affect liver transplantation outcome

Progress in Transplantation

Volumn 14, Issue 3, 2004, Pages 241-249

  Powner, David J ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ENDOTOXIN; GLYCOGEN; SODIUM; VASOACTIVE AGENT;

AGE; BLOOD GROUP ABO SYSTEM; BLOOD PRESSURE; CAUSE OF DEATH; CLINICAL TRIAL; COLD ISCHEMIA; COLD ISCHEMIA TIME; DATA BASE; FATTY LIVER; GLYCOGEN LIVER LEVEL; GRAFT SURVIVAL; HOSPITALIZATION; HUMAN; HYPERNATREMIA; HYPOTENSION; INTENSIVE CARE; ISCHEMIA; LIVER TRANSPLANTATION; LIVING DONOR; META ANALYSIS; NUTRITION; ORGAN DONOR; OUTCOMES RESEARCH; PATIENT CARE; PUBLICATION; RECIPIENT; REPERFUSION INJURY; REVIEW; RISK FACTOR; SEX DIFFERENCE; SODIUM BLOOD LEVEL; SYSTEMATIC REVIEW;

EID: 4444303520     PISSN: 15269248     EISSN: None     Source Type: Journal    
DOI: 10.7182/prtr.14.3.d36p8205k2025274     Document Type: Review

References (45)

1. Strasberg SM, Howard TK, Molmenti EP, Hertl M. Selecting the donor liver: risk factors for poor function after orthotopic liver transplantation. Hepatology. 1994;20:829-838.
2. Maring JK, Klompmaker IJ, Zwaveling JH, Kranenburg K, Ten Vergert EM, Slooff MJH. Poor initial graft function after orthotopic liver transplantation: can it be predicted and does it affect outcome? An analysis of 125 adult primary transplantations. Clin Transplant. 1997;11:373-379.
3. Tullius SG, Volk HD, Neuhaus P. Transplantation of organs from marginal donors. Transplantation. 2001;72:1341-1349.
4. Tuttle-Newhall JE, Collins BH, Kuo PC, Schoeder R. Organ donation and treatment of the multi-organ donor. Curr Probl Surg. 2003;40:266-310.
5. Shaked A, Nunes FA, Olthoff KM, Lucey MR. Assessment of liver function: pre- and peritransplant evaluation. Clin Chem. 1997;43:1539-1545.
6. Greig PD, Forster J, Superina RA, et al. Donor-specific factors predict graft function following liver transplantation. Transplant Proc. 1990;22:2072-2073.
7. Brokelman W, Stel AL, Ploeg RJ. Risk factors for primary dysfunction after liver transplantation in the University of Wisconsin solution era. Transplant Proc. 1999;31:2087-2090.
8. Mimeault R, Grant D, Ghent C, Duff J, Wall W. Analysis of donor and recipient variables and early graft function after orthotopic liver transplantation. Transplant Proc. 1989; 21:3355.
9. Ploeg RJ, D'Alessandro AM, Knechtle SJ, et al. Risk factors for primary dysfunction after liver transplantation: a multivariate analysis. Transplantation. 1993;55:807-813.
10. Figueras J, Busquets J, Grande L, et al. The deleterious effect of donor high plasma sodium and extended preservation in liver transplantation. Transplantation. 1996;61:410-413.
11. Alexander JW, Vaugn WK. The use of "marginal" donors for organ transplantation. Transplantation. 1991;51:135-141.
12. Briceno J, Marchai T, Padillo J, Solorzano G, Pera C. Influence of marginal donors on liver preservation injury. Transplantation. 2002;74:522-526.
13. Yersiz H, Snaked A, Olthoff K, et al. Correlation between donor age and the pattern of liver graft recovery after transplantation. Transplantation. 1995;60:790-794.
14. Busquets J, Xiol X, Figueras J, et al. The impact of donor age on liver transplantation: influence of donor age on early liver function and on subsequent patient and graft survival. Transplantation. 2001;71:1765-1771.
15. Kizilisik TA, Al-Sebayel M, Ramierz CB, et al. Analysis of donor criteria and its implications on the outcome of clinical liver transplants. Transplant Proc. 1997;29:2836-2838.
16. Lee YJ, Lee SG, Kwon TW, Park KM, Kim SC, Min PC. Donor characteristics for liver transplantation and risk factors for early poor graft function and survival. Transplant Proc. 1996;28:1663-1664.
17. Jonas S, Bechstein WO, Keck H, Lemmens HP, Blumhardt G, Neuhaus P. Donor criteria in hepatic transplantation. Langenbecks Arch Chir. 1994;379:8-12.
18. Gonzalez FX, Rimola A, Grande L, et al. Predictive factors of early postoperative graft function in human liver transplantation. Hepatology. 1994;20:565-573.
19. Avolio AW, Agnes S, Magalini SC, Foco M, Castagneto M. Importance of donor blood chemistry data (AST, serum sodium) in predicting liver transplant outcome. Transplant Proc. 1991;23:2451-2452.
20. Briceno J, Lopez-Cillero P, Rufian S, et al. Impact of marginal quality donors on the outcome of liver transplantation. Transplant Proc. 1997;29:477-480.
21. Verran DJ, Gurkan A, Dilworth P, et al. Inferior liver allograft survival from cadaveric donors >50 years of age? Clin Transplant. 2001;15:106-110.
22. Oh CK, Sanfey HA, Pelletier SJ, Sawyer RG, McCullough CS, Pruett TL. Implication of advanced donor age on the outcome of liver transplantation. Clin Transplant. 2000;14:386-390.
23. Gruenberger T, Steininger R, Sautner T, Mittlbock M, Muhlbacher F. Influence of donor criteria on postoperative graft function after orthotopic liver transplantation. Transpl Int. 1994;7(suppl 1):S672-S674.
24. Totsuka E, Dodson F, Urakami A, et al. Influence of high donor serum sodium levels on early postoperative graft function in human liver transplantation: effect of correction of donor hypernatremia. Liver Transplant Surg. 1999; 5:421-428.
25. Brooks BK, Levy MF, Jennings LW, et al. Influence of donor and recipient gender on the outcome of liver transplantation. Transplant Proc. 1997;29:475-476.
26. Makowka L, Gordon RD, Todo S, et al. Analysis of donor criteria for the prediction of outcome in clinical liver transplantation. Transplant Proc. 1987;19:2378-2382.
27. delaTorre AN, Kuo PC, Plotkin JS, et al. Influence of donor base deficit status on recipient outcomes in liver transplantation. Transplant Proc. 1997;29:474.
28. Kahn D, Makowka L, Cavaler J, Starzl TE, Van Thiel DH. The outcome after clinical liver transplantation is influenced by the gender of the donor. Hepatology. 1988;8:1225.
29. Koneru B, Dikdan G. Hepatic steatosis and liver transplantation current clinicals and experimental perspectives. Transplantation. 2002;73:325-330.
30. Pillay SP, Moore TD, Lynch SV, Whiting RF, Balderson GA, Strong RW. Endotoxin levels in adult liver donors. Aust N Z J Surg. 1994;64:615-617.
31. Palombo JD, Burke PA, Moldawer LL, Forse RA, Lewis WD, Jenkins RL. Assessment of the cytokine response in liver donors at the time of organ procurement and association with allograft function after orthotopic transplantation. J Am Coll Surg. 1994;179:209-219.
32. Singer P, Cohen J, Cynober L. Effect of nutritional state of brain-dead organ donor on transplantation. Nutrition. 2001; 17:948-952.
33. Adam R, Reynes M, Bao YM, et al. Impact of glycogen content of the donor liver in clinical liver transplantation. Transplant Proc. 1993;25:1536-1537.
34. Boudjema K, Lindell SL, Southard JH, Beizer FO. The effects of fasting on the quality of liver preservation by simple cold storage. Transplantation. 1990;50:943-948.
35. Palombo JD, Hirschberg Y, Pomposelli JJ, Blackburn GL, Zeisel SH, Bistrian BR. Decreased loss of liver nucleotides and energy charge during hypothermie preservation by donor pretreatment with glucose: a preliminary report. Transplant Proc. 1989;21:1299-1300.
36. Lanir A, Jenkins RL, Caldwell C, Lee RGL, Khettry U, Clouse ME. Hepatic transplantation survival: correlation with adenine nucleotide level in donor liver. Hepatology. 1988; 8:471-475.
37. Cywes R, Greig PD, Sanabria JR, et al. Effect of intraportal glucose infusion on hepatic glycogen content and degradation, and outcome of liver transplantation. Ann Surg. 1992;216:235-247.
38. Kamike W, Burdelski M, Steinhoff G, Ringe B, Lauchart W, Pichlmayr R. Adenine nucleotide metabolism and its relation to organ viability in human liver transplantation. Transplantation. 1988;45:138-143.
39. Powner DJ, Darby JM. Management of variations in blood pressure during care of organ donors. Prog Transplant. 2000; 10:25-32.
40. Powner DJ, Darby JM, Kellum JA. Proposed treatment guidelines for donor care. Prog Transplant. March 2004;14:16-26.
41. Carini R, Albano E. Recent insights on the mechanism of liver preconditioning. Gastroenterology. 2003;125:1480-1489.
42. Serafin A, Fernandez-Zabalegui L, Prats N, et al. Ischemic preconditioning: tolerance to ischemia-reperfusion injury. Histol Histopathol 2004;19:281-289.
43. Totsuka E, Fung JJ, Urakami A, et al. Influence of donor cardiopulmonary arrest in human liver transplantation: possible role of ischemic preconditioning. Hepatology. 2000;31:577-580.
44. Wilson DJ, Fisher A, Das K, et al. Donors with cardiac arrest: improved organ recovery but no preconditioning benefit in liver allografts. Transplantation. 2003;75:1683-1687.
45. Berrevoet F, Schafer T, Vollmar B, Menger MD. Ischemic preconditioning: enough evidence to support clinical application in liver surgery and transplantation? Acta Chir Belg. 2003;103:485-489.